ResearcherActive in the last 2 years

Meredith L. Stone

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0000-0001-6087-1180; OpenAlex author ID A5026364259.

Their work

Papers: 5 (first author 2, last author 0)
Trials: 0
Grants: 1
Collaborators: 11

Papers, trials and grants by year

2019: 1 paper · 2020: 1 grant · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 5

TLR2 signaling regulates T cell exclusion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci.insight.195329 ↗
Nonredundant Immune Checkpoints Direct Therapeutic Resistance to Chemoimmunotherapy in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1158/2326-6066.cir-25-0575 ↗
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2024.101397 ↗
Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice. Co-author DOI 10.1038/s41467-023-41771-z ↗
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer. First author DOI 10.1016/j.pharmthera.2019.05.012 ↗

Grants 1

Targeting Hepatocyte-Derived Factors to Improve the Efficacy of Immunotherapy in Pancreatic Cancer CDMRP award

Closest collaborators

The 11 strongest of 11 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Gregory Lawrence Beatty · 5 shared papers, 2019–2026
Jacqueline B. Plesset · 1 shared paper, 2026
- Paper TLR2 signaling regulates T cell exclusion in pancreatic ductal adenocarcinoma. DOI 10.1172/jci.insight.195329 ↗
Anna S. Thickens · 1 shared paper, 2026
- Paper TLR2 signaling regulates T cell exclusion in pancreatic ductal adenocarcinoma. DOI 10.1172/jci.insight.195329 ↗
John C. McVey · 1 shared paper, 2026
- Paper TLR2 signaling regulates T cell exclusion in pancreatic ductal adenocarcinoma. DOI 10.1172/jci.insight.195329 ↗
Jae Woo Lee · 1 shared paper, 2024
- Paper Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. DOI 10.1016/j.xcrm.2024.101397 ↗
Yan Li · 1 shared paper, 2024
- Paper Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. DOI 10.1016/j.xcrm.2024.101397 ↗
Joey H. Li · 1 shared paper, 2024
- Paper Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. DOI 10.1016/j.xcrm.2024.101397 ↗
Nicole Groß · 1 shared paper, 2024
- Paper Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. DOI 10.1016/j.xcrm.2024.101397 ↗
Won Jin Ho · 1 shared paper, 2024
- Paper Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. DOI 10.1016/j.xcrm.2024.101397 ↗
Max Miller Wattenberg · 1 shared paper, 2023
- Paper Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice. DOI 10.1038/s41467-023-41771-z ↗
Stacy K. Thomas · 1 shared paper, 2023
- Paper Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice. DOI 10.1038/s41467-023-41771-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.